Baudax Bio Inc. (BXRX) PT Lowered to $2 at Oppenheimer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Baudax Bio Inc. (BXRX) PT Lowered to $4 at JMP Securities
May 6, 2021 3:00 AM EDTJMP Securities analyst Jason Butler lowered the price target on Baudax Bio Inc. (NASDAQ: BXRX) to $4.00 (from $5.00) while maintaining a Market Outperform rating.... More
Baudax Bio (BXRX) Misses Q1 EPS by 8c
May 5, 2021 7:27 AM EDTBaudax Bio (NASDAQ: BXRX) reported Q1 EPS of ($0.27), $0.08 worse than the analyst estimate of ($0.19).
The first quarter has been busy and fruitful at Baudax. ANJESO sustained marked progress in the areas of new account wins, increasing units sold, reorder rates, and deepening usage... More
